Skip to main content

NCBiotech News

  • Bioscience briefs with names making news
  • One of the most significant incubators of small businesses in North Carolina is celebrating National Small Business Week with a visit from its district’s Congressman. And all four First Flight Venture Center (FFVC) startup companies making “Shark Tank”-type pitches to the audience are being bootstrapped with loans from the North Carolina Biotechnology Center.
  • Global generic drug maker Aurobindo Pharma said today it will invest over $31.7 million to establish a new national headquarters in Durham that will  bring 275 new R&D and pharmaceutical manufacturing jobs to the Triangle.
  • The North Carolina Biotechnology Center awarded 21 grants and loans totaling $2.5 million to companies, universities and nonprofit organizations across the state during the third quarter of its 2015-2016 fiscal year ending March 31.
  • Bioscience briefs with names making news
  • Two North Carolina companies are among 39 biotechnology firms competing in a Buzz of BIO contest to recognize the most innovative companies prior to this summer’s BIO International Convention in San Francisco, June 6-9.
  • Bayer's crop science division hosted more than 160 fifth graders and high school students from central North Carolina this week at its Research Triangle Park campus, letting the students tour facilities, talked with Bayer staff and participate in hands-on exercises demonstrating how new crop seeds and ag chemicals move from an idea in someone’s mind to a product used in a farmer’s field.
  • Durham’s Deep Blue Medical Advances, founded in 2014 by a plastic surgeon as an incubator for developing Duke medical device inventions, is the sole bioscience-related semifinalist in the spring 2016 round of NC IDEA grants.
  • A pioneering researcher at North Carolina State University, Rodolphe Barrangou, Ph.D., will tell the public Monday evening how he’s cutting and pasting his way to new discoveries in the adaptive bacterial immune system known as CRISPR.
  • Medical Murray is celebrating 20 years of innovation and expansion in the medical device industry on April 1, 2016, mere months after open house festivities at a new Medical Murray Southeast building near the Charlotte Douglas International Airport.
  • Novo Nordisk has officially begun building a $1.8 billion production facility for diabetes medicines at its Clayton site that will create 700 high-paying jobs, doubling its workforce there.
  • Morris Clarke, Ph.D., associate professor of biochemistry at Winston-Salem State University, has been named leader of the Executive Council of the Advisory Committee for Biotechnology in the Piedmont Triad as new members also join the advisory committee.
  • Duke University has purchased an exclusive sublicense from former NC biotech company PhaseBio Pharmaceuticals to use some of the firm's technology in developing long-acting cancer drugs with minimal toxic side effects.
  • Doug Edgeton, president and CEO of the North Carolina Biotechnology Center, is among a dozen corporate leaders nominated for a 2016 “Full Steam Ahead” award in a contest sponsored by WRAL TechWire.
  • Morrisville-based Envisia Therapeutics, a clinical-stage biotechnology company focused on developing novel therapies for eye diseases, has raised $16.5 million in additional Series A financing from existing investors.
  • Braeburn Pharmaceuticals, a 4-year-old Princeton, N.J., company developing drugs with specialized delivery technologies to improve treatments for mental illness, pain and addiction, plans to invest nearly $20 million over five years to establish a manufacturing and R&D hub in Durham that will create 52 new jobs.
  • Craft Technologies, a small contract laboratory in Wilson, has received $844,395 from the Bill & Melinda Gates Foundation for analytical work aimed at improving nutrition in the developing world.
  • Almac Group, a global CRO based in Northern Ireland, has opened a new development facility for companion diagnostics in Durham.
  • A family-owned German company called Raumedic has opened a $27 million development and production facility in western North Carolina to make medical and pharmaceutical plastic and rubber components.
  • Blood therapeutics company Grifols said it will invest $210 million to build two new facilities at its Clayton campus.

Pages

Subscribe to News & Events